SCHEMBL18347472

SCHEMBL18347472

N#Cc1cccc(-n2c3ccc(C#N)cc3c3cccc(-c4ccccc4-c4ccccc4-n4c5ccccc5c5cc(C#N)ccc54)c32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 1/20 0.37
NOTUM Q6P988 1/20 0.36
MAT2A P31153 2/20 0.34
SLC2A1 P11166 1/20 0.34
SLC2A2 P11168 1/20 0.34
SLC2A3 P11169 1/20 0.34
GRM5 P41594 6/20 0.33
ALDH1A1 P00352 2/20 0.33
PTGER4 P35408 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
DUSP3 P51452 1/20 0.33
HPGD P15428 1/20 0.33
TDP2 O95551 1/20 0.33
TNF P01375 1/20 0.33
LITAF Q99732 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18347470 1.00 RPS6KB1 (0.37) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2
SCHEMBL18347425 1.00 RPS6KB1 (0.37) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2
SCHEMBL18347424 0.95 RPS6KB1 (0.39) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2
SCHEMBL18347449 0.92 PTGER4 (0.36) RPS6KB1PTGER4DUSP3TDP2KDM4E
SCHEMBL18347471 0.92 PTGER4 (0.36) RPS6KB1PTGER4DUSP3TDP2KDM4E
SCHEMBL18347419 0.92 PTGER4 (0.36) RPS6KB1PTGER4DUSP3TDP2KDM4E
SCHEMBL18348431 0.92 KDM4E (0.41) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2
SCHEMBL18348428 0.92 KDM4E (0.41) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2
SCHEMBL18348383 0.92 KDM4E (0.41) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2
SCHEMBL18348371 0.92 KDM4E (0.41) RPS6KB1NOTUMMAT2ASLC2A1SLC2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160380210-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380210-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 RPS6KB1 2579/4885NOTUM 2583/4885MAT2A 4038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.